Plastic bottles transformed into Parkinson’s drug using bacteria

Professor Stephen Wallace harvesting engineered bacteria for analysis. CREDIT: Edinburgh Innovations

A drug to treat Parkinson’s disease can be made from waste plastic bottles using a pioneering method, a study shows.

The approach harnesses the power of bacteria to transform post-consumer plastic into L-DOPA, a frontline medication for the neurological disorder.

It is the first time a natural, biological process has been engineered to turn plastic waste into a therapeutic for a neurological disease, researchers say.

Scientists at the University of Edinburgh engineered E. coli bacteria to turn a type of plastic used widely in food and drink packaging – polyethylene terephthalate, or PET – into L-DOPA.

The process involves first breaking down PET waste – some 50 million tonnes of which are produced annually – into chemical building blocks of terephthalic acid. Molecules of terephthalic acid are then transformed into L-DOPA by the engineered bacteria through a series of biological reactions.

Using the new technique to produce L-DOPA is more sustainable than traditional methods of making pharmaceuticals, which rely on the use of finite fossil fuels, the team says.

There is an urgent need for new methods to recycle PET, a strong, lightweight plastic derived from non-renewable materials such as oil and gas, the team says. Existing recycling processes are not completely efficient and still contribute to plastic pollution worldwide.

The advance offers a sustainable way of repurposing valuable carbon in plastic waste that would otherwise be lost to landfill, incineration or environmental pollution, the team says. It could pave the way for growth of a bio-upcycling industry for producing not only pharmaceuticals but a wide range of products including flavourings, fragrances, cosmetics, and industrial chemicals, they add.

Having now demonstrated the production and isolation of L-DOPA at gram-per-litre scale[CC1] , the team will next focus on advancing the technology towards industrial application.

This will involve further optimising the process, improving its efficiency and scalability, and further assessing its environmental and economic performance.

The findings are published in the journal Nature Sustainability. The research was funded by UK Research and Innovation (UKRI) and the Industrial Biotechnology Innovation Centre (IBioIC), with test lab and innovation centre Impact Solutions as an industry partner. The research is supported by Edinburgh Innovations, the University of Edinburgh’s commercialisation service.

Professor Stephen Wallace, of the University of Edinburgh’s School of Biological Sciences, who led the study, said:

“This feels like just the beginning. If we can create medicines for neurological disease from a waste plastic bottle, it’s exciting to imagine what else this technology could achieve. Plastic waste is often seen as an environmental problem, but it also represents a vast, untapped source of carbon. By engineering biology to transform plastic into an essential medicine, we show how waste materials can be reimagined as valuable resources that support human health.”

Dr Susan Bodie, Director of Innovation Development and Licensing at Edinburgh Innovations, said TBC: “Professor Wallace is one of several pioneering researchers at the University using innovative and sustainable engineering biology techniques to valorise waste, including with industry partners as part of the new Carbon Loop Hub. These techniques could help bring about a green revolution in industrial manufacture in the UK and beyond, and we would urge companies interested in working with us to get in touch.”

Dr Liz Fletcher, director of impact and deputy CEO at IBioIC, said: “This project highlights the potential of biology to reshape the way we think about waste. Turning plastic bottles into a Parkinson’s drug isn’t just a creative recycling idea, it’s a way of redesigning processes that work with nature to deliver real-world benefits. By demonstrating that a harmful material can be converted into something that improves human health, the team is proving that sustainable, high-value applications of biology are both practical and effective.”